![Gerald Hogue](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gerald Hogue is the founder of OpTx Corp.
(founded in 1993) and Viviphi Ltd. (founded in 2015, title: Chairman, President & Chief Executive Officer).
Mr. Hogue is currently a Director at POINT Biopharma, Inc. (since 2020).
Formerly, Independent Director at POINT Biopharma Global, Inc. (2021-2023).
| Företag | Position | Start |
|---|---|---|
POINT Biopharma, Inc. (United States)
 POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer | Direktör/Styrelseledamot | 2020-12-01 |
| Företag | Position | Slut |
|---|---|---|
| POIT BIOP | Direktör/Styrelseledamot | 2023-12-27 |
Viviphi Ltd.
 Viviphi Ltd. Packaged SoftwareTechnology Services Provides artificial intelligence informatics software platform for cancer care | Verkställande Direktör | 2023-12-01 |
OpTx Corp.
 OpTx Corp. Packaged SoftwareTechnology Services Provides oncology-specific software and services providers | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
| Privata företag | 4 |
|---|---|
OpTx Corp.
OpTx Corp. Packaged SoftwareTechnology Services Provides oncology-specific software and services providers | Technology Services |
Viviphi Ltd.
Viviphi Ltd. Packaged SoftwareTechnology Services Provides artificial intelligence informatics software platform for cancer care | Technology Services |
POINT Biopharma Global, Inc.
 POINT Biopharma Global, Inc. BiotechnologyHealth Technology Develops radioligand therapies for the treatment of cancer | Health Technology |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Develops next-generation radioligand therapies for the treatment of cancer | Commercial Services |
Välj din utgåva
All finansiell information anpassad till den nationella nivån
